ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,222.68
      0.16%
      US Tech 100
      17,650.00
      0.05%
      Dow Jones
      39,512.84
      0.32%
      Brent Oil
      82.585
      0.00%
      Bitcoin
      61,616.74
      1.35%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Daxor Corporation (DXR)

      7. Daxor Corporation (DXR) News

      DXR

      Daxor (DXR)

      Daxor Corporation
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:DXR
      DateTimeSourceHeadlineSymbolCompany
      04/16/20248:00AMGlobeNewswire Inc.New Studies Prove the Clinical Benefits of Daxor’s Blood Volume (BVA-100TM) Diagnostic In Ambulatory Heart Failure Patients For Measurement of CongestionNASDAQ:DXRDaxor Corporation
      04/15/20248:00AMGlobeNewswire Inc.DAXOR CORPORATION TO EXHIBIT AT THE MEDAXIOM CARDIOVASCULAR TRANSFORUM CONFERENCE SPRING’24 TO ADVANCE AWARENESS AND FURTHER ADOPTION OF DAXOR’S BLOOD VOLUME DIAGNOSTIC (BVA-100™)NASDAQ:DXRDaxor Corporation
      04/10/20248:00AMGlobeNewswire Inc.Daxor Corporation Announces New Hospital Account at Leading Chicago HospitalNASDAQ:DXRDaxor Corporation
      04/01/20248:00AMGlobeNewswire Inc.Daxor Corporation to Exhibit at the American College of Cardiology for ACC.24NASDAQ:DXRDaxor Corporation
      03/25/20248:00AMGlobeNewswire Inc.Daxor Corporation Acquires Volumex® and Megatope® From Its Existing Supplier Along With Glofil® to Enhance Existing Suite of DiagnosticsNASDAQ:DXRDaxor Corporation
      03/22/20248:00AMGlobeNewswire Inc.Daxor Corporation to Hold Investor Call Discussing Fiscal Year 2023 Financial Results and Corporate Update on March 25, 2024NASDAQ:DXRDaxor Corporation
      03/18/20242:18PMGlobeNewswire Inc.Daxor Corporation Reports Increase in NAV to $7.08 Per Share and 31.8 Percent Increase in Unaudited Revenue of Operating Division for the Year Ended December 31, 2023NASDAQ:DXRDaxor Corporation
      03/18/20242:18PMGlobeNewswire Inc.Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to ShareholdersNASDAQ:DXRDaxor Corporation
      03/11/20248:00AMGlobeNewswire Inc.Daxor Announces Sales to Three New Hospitals Furthering Expansion of Its User BaseNASDAQ:DXRDaxor Corporation
      03/08/20241:49PMEdgar (US Regulatory)Form NT-NCSR/A - Notice under Exchange Act Rule 12b-25 of inability to timely file Form N-CSR (annual or semi-annual report): [Amend]NASDAQ:DXRDaxor Corporation
      03/08/20248:00AMGlobeNewswire Inc.Multi-Center Study Presented by Duke at Heart Failure Therapeutics Conference Highlights Daxor’s Unique Clinical Utility for Heart Failure PatientsNASDAQ:DXRDaxor Corporation
      03/06/20244:18PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DXRDaxor Corporation
      02/29/20245:28PMEdgar (US Regulatory)Form NT-NCSR/A - Notice under Exchange Act Rule 12b-25 of inability to timely file Form N-CSR (annual or semi-annual report): [Amend]NASDAQ:DXRDaxor Corporation
      02/29/20244:15PMEdgar (US Regulatory)Form NT-NCSR - Notice under Exchange Act Rule 12b-25 of inability to timely file Form N-CSR (annual or semi-annual report)NASDAQ:DXRDaxor Corporation
      02/26/20248:00AMGlobeNewswire Inc.Daxor Corporation to Exhibit at the Technology and Heart Failure Therapeutics ConferenceNASDAQ:DXRDaxor Corporation
      02/12/20248:00AMGlobeNewswire Inc.Daxor Corporation Starts 2024 with Ongoing Growth in New Blood Volume Analyzer AcquisitionsNASDAQ:DXRDaxor Corporation
      02/07/20248:00AMGlobeNewswire Inc.Daxor Corporation Closes Q4 2023 with Growth in New Sales to Hospital Systems and Increased Utilization of its BVA-100® Blood Volume Diagnostic Across the U.S. at Existing AccountsNASDAQ:DXRDaxor Corporation
      01/29/20248:00AMGlobeNewswire Inc.Daxor Corporation to Exhibit at the Society of Nuclear Medicine and Molecular Imaging Mid-Winter and American College Nuclear Medicine Annual MeetingNASDAQ:DXRDaxor Corporation
      01/16/20248:00AMGlobeNewswire Inc.Daxor Corporation to Exhibit at the Society for Critical Care Medicine 2024 Critical Care CongressNASDAQ:DXRDaxor Corporation
      01/09/20248:00AMGlobeNewswire Inc.DAXOR AWARDED ADDITIONAL NEW PATENT FOR SMART BLOOD VOLUME GUIDANCE TECHNOLOGY TO IMPROVE TREATMENT AND OUTCOMESNASDAQ:DXRDaxor Corporation
      01/02/20248:52AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DXRDaxor Corporation
      01/02/20248:30AMGlobeNewswire Inc.Daxor Corporation Submits Dual 510(k)/CLIA-waiver Application to the FDA for Its Advanced Next-Generation Blood Volume AnalyzerNASDAQ:DXRDaxor Corporation
      12/06/20233:48PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DXRDaxor Corporation
      12/01/20239:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DXRDaxor Corporation
      12/01/20239:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DXRDaxor Corporation
      12/01/20238:58PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DXRDaxor Corporation
      12/01/20238:58PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DXRDaxor Corporation
      11/27/20236:03AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DXRDaxor Corporation
      11/24/20231:53PMEdgar (US Regulatory)Form NPORT-P - Monthly Portfolio Investments Report on Form N-PORT (Public)NASDAQ:DXRDaxor Corporation
      11/24/202311:32AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DXRDaxor Corporation
       Showing the most relevant articles for your search:NASDAQ:DXR